Nicergoline (BioDeep_00000398536)
代谢物信息卡片
Nicergoline
化学式: C24H26BrN3O3 (483.1157426000001)
中文名称: 尼麦角林
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C(C(OC)41)([H])(N(C)CC(COC(=O)c(c5)cc(Br)cn5)C4)Cc(c3)c(c2n(C)3)c1ccc2
InChI: InChI=1S/C24H26BrN3O3/c1-27-13-17-8-21-24(30-3,19-5-4-6-20(27)22(17)19)9-15(12-28(21)2)14-31-23(29)16-7-18(25)11-26-10-16/h4-7,10-11,13,15,21H,8-9,12,14H2,1-3H3
描述信息
C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AE - Ergot alkaloids
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
D002491 - Central Nervous System Agents > D018697 - Nootropic Agents
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.982
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.978
Nicergoline, an ergoline derivative ester of bromonicotinic acid, is a potent, selective and orally active antagonist of α1A-adrenoceptor. Nicergoline has vasodilator effects. Nicergoline also has ameliorative effects on cognitive function in mouse models of Alzheimer's disease[1][2].
同义名列表
1 个代谢物同义名
数据库引用编号
20 个数据库交叉引用编号
- ChEBI: CHEBI:31902
- KEGGdrug: D01290
- PubChem: 34040
- Metlin: METLIN1510
- DrugBank: DB00699
- ChEMBL: CHEMBL1372950
- MeSH: Nicergoline
- CAS: 27848-84-6
- MoNA: WA002681
- MoNA: WA002680
- MoNA: WA002679
- MoNA: WA002678
- MoNA: WA002677
- MoNA: WA002676
- MoNA: BML81797
- MoNA: BML81795
- MoNA: BML00301
- MoNA: BML00292
- MoNA: BML00283
- medchemexpress: HY-B0702
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Peterson Anand, Alan G S Harper. Human platelets use a cytosolic Ca2+ nanodomain to activate Ca2+-dependent shape change independently of platelet aggregation.
Cell calcium.
2020 09; 90(?):102248. doi:
10.1016/j.ceca.2020.102248. [PMID: 32629299] - Lionel Sebbag, Leah M Moody, Rachel A Allbaugh, Jonathan P Mochel. Nerve growth factor in dogs: Assessment of two immunoassays and selected ocular parameters following a nicergoline challenge per os.
Veterinary ophthalmology.
2020 Jan; 23(1):199-204. doi:
10.1111/vop.12723. [PMID: 31774231] - Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology.
2019 11; 96(5):629-640. doi:
10.1124/mol.119.115964. [PMID: 31515284] - Da-Hai Yang, Ian T Baldwin, Jianqiang Wu. Silencing brassinosteroid receptor BRI1 impairs herbivory-elicited accumulation of jasmonic acid-isoleucine and diterpene glycosides, but not jasmonic acid and trypsin proteinase inhibitors in Nicotiana attenuata.
Journal of integrative plant biology.
2013 Jun; 55(6):514-26. doi:
10.1111/jipb.12035. [PMID: 23347255] - O A Levada, A V Traïlin. [Serum level of S100B as a marker of progression of vascular mild cognitive impairment into subcortical vascular dementia and therapy effectiveness].
Likars'ka sprava.
2012 Apr; ?(3-4):53-9. doi:
NULL. [PMID: 23356138] - Sui Cheung Man, Kam Wa Chan, Jia-Hong Lu, Siva Sundara Kumar Durairajan, Liang-Feng Liu, Min Li. Systematic review on the efficacy and safety of herbal medicines for vascular dementia.
Evidence-based complementary and alternative medicine : eCAM.
2012; 2012(?):426215. doi:
10.1155/2012/426215. [PMID: 22235231] - Taku Nakashima, Noboru Hattori, Mafumi Okimoto, Jitsuro Yanagida, Nobuoki Kohno. Nicergoline improves dysphagia by upregulating substance P in the elderly.
Medicine.
2011 Jul; 90(4):279-283. doi:
10.1097/md.0b013e318224413b. [PMID: 21694649] - Jacek Sapa, Alicja Nowaczyk, Katarzyna Kulig. Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties.
Naunyn-Schmiedeberg's archives of pharmacology.
2011 Jan; 383(1):13-25. doi:
10.1007/s00210-010-0566-x. [PMID: 20949258] - Yasuhiro Nishiyama, Arata Abe, Masayuki Ueda, Ken-ichiro Katsura, Yasuo Katayama. Nicergoline increases serum substance P levels in patients with an ischaemic stroke.
Cerebrovascular diseases (Basel, Switzerland).
2010 Jan; 29(2):194-8. doi:
10.1159/000267279. [PMID: 20029189] - Gennady A Buznikov, Lyudmila A Nikitina, Frederic J Seidler, Theodore A Slotkin, Vladimir V Bezuglov, Ivan Milosević, Lidija Lazarević, Ljubica Rogac, Sabera Ruzdijić, Ljubisa M Rakić. Amyloid precursor protein 96-110 and beta-amyloid 1-42 elicit developmental anomalies in sea urchin embryos and larvae that are alleviated by neurotransmitter analogs for acetylcholine, serotonin and cannabinoids.
Neurotoxicology and teratology.
2008 Nov; 30(6):503-9. doi:
10.1016/j.ntt.2008.05.003. [PMID: 18565728] - Mohamed I Walash, Fathalla Belal, Nahed El-Enany, Amina Abdelal. Second-derivative synchronous fluorescence spectroscopy for the simultaneous determination of cinnarizine and nicergoline in pharmaceutical preparations.
Journal of AOAC International.
2008 Mar; 91(2):349-59. doi:
NULL. [PMID: 18476347] - Han Yan, Lin Li, Xi Can Tang. Treating senile dementia with traditional Chinese medicine.
Clinical interventions in aging.
2007; 2(2):201-8. doi:
". [PMID: 18044136] - James David Adams, Rubin Wang, Jun Yang, Eric Jungchi Lien. Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions.
Chinese medicine.
2006 Nov; 1(?):3. doi:
10.1186/1749-8546-1-3. [PMID: 17302964] - Antonio Moschetta, Fang Xu, Lee R Hagey, Gerard P van Berge-Henegouwen, Karel J van Erpecum, Jos F Brouwers, Jonathan C Cohen, Molly Bierman, Helen H Hobbs, Joseph H Steinbach, Alan F Hofmann. A phylogenetic survey of biliary lipids in vertebrates.
Journal of lipid research.
2005 Oct; 46(10):2221-32. doi:
10.1194/jlr.m500178-jlr200. [PMID: 16061950] - Mariapia Vairetti, Angelo Battaglia, Nicola Carfagna, Pier Luigi Canonico, Francantonio Bertè, Plinio Richelmi. Antioxidant properties of MDL and MMDL, two nicergoline metabolites, during chronic administration of haloperidol.
European journal of pharmacology.
2002 Oct; 453(1):69-73. doi:
10.1016/s0014-2999(02)02386-5. [PMID: 12393061] - E Ezan, L Delestre, S Legendre, R Rivière, J L Doignon, J M Grognet. Immunoassays for the detection of nicergoline and its metabolites in human plasma.
Journal of pharmaceutical and biomedical analysis.
2001 Apr; 25(1):123-30. doi:
10.1016/s0731-7085(00)00501-x. [PMID: 11274866] - E Iwata, I Miyazaki, M Asanuma, A Iida, N Ogawa. Protective effects of nicergoline against hydrogen peroxide toxicity in rat neuronal cell line.
Neuroscience letters.
1998 Jul; 251(1):49-52. doi:
10.1016/s0304-3940(98)00489-3. [PMID: 9714462] - A Robert, N N Tran, P Giummelly, J Atkinson, C Capdeville-Atkinson. Sensitivity of norepinephrine-evoked vasoconstriction to pertussis toxin in the old rat.
The American journal of physiology.
1998 06; 274(6):R1604-12. doi:
10.1152/ajpregu.1998.274.6.r1604. [PMID: 9608014] - M Tanaka, T Yoshida, K Okamoto, S Hirai. Antioxidant properties of nicergoline; inhibition of brain auto-oxidation and superoxide production of neutrophils in rats.
Neuroscience letters.
1998 May; 248(1):68-72. doi:
10.1016/s0304-3940(98)00310-3. [PMID: 9665666] - Y Böttiger, P Dostert, M S Benedetti, M Bani, F Fiorentini, M Casati, I Poggesti, C Alm, G Alvan, L Bertilsson. Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humans.
British journal of clinical pharmacology.
1996 Dec; 42(6):707-11. doi:
10.1046/j.1365-2125.1996.00471.x. [PMID: 8971425] - P Chen, Z Tian, G A Digenis, H H Tai. Enzyme immunoassay of two nicergoline metabolites, 10 alpha-methoxy-9, 10-dihydrolysergol (MDL) and 1-methyl-10 alpha-methoxy-9, 10-dihydrolysergol (MMDL).
Research communications in molecular pathology and pharmacology.
1996 Jun; 92(3):315-28. doi:
NULL. [PMID: 8827829] - F Gabor, G Hamilton, F Pittner. Drug-protein conjugates: haptenation of 1-methyl-10 alpha-methoxydihydrolysergol and 5-bromonicotinic acid to albumin for the production of epitope-specific monoclonal antibodies against nicergoline.
Journal of pharmaceutical sciences.
1995 Sep; 84(9):1120-5. doi:
10.1002/jps.2600840916. [PMID: 8537892] - I Tilser. The effect of pretreatment with prostaglandin E2 (PGE2), verapamil, nicergoline and bromocriptine on ischemia-reperfusion injury of rat liver in vivo.
Sbornik vedeckych praci Lekarske fakulty Karlovy university v Hradci Kralove.
1994; 37(1):19-24. doi:
NULL. [PMID: 7761787] - M Yasui, T Kihira, M Tsujimoto, K Ota. Effects of nicergoline on calcium and magnesium deposition in the central nervous system tissues of rats maintained on low-calcium diets.
The Journal of international medical research.
1992 Nov; 20(6):483-91. doi:
10.1177/030006059202000606. [PMID: 1286741] - I Sh Vesel'skiĭ, N N Gritsaĭ. [The correction of lipid peroxidation metabolism, the hemostatic system and cerebral hemodynamics in patients with the initial manifestations of cerebral circulatory insufficiency].
Likars'ka sprava.
1992 Jul; ?(7):50-2. doi:
". [PMID: 1448987] - M Yasui, T Kihira, K Ota, K Funahashi, N Komai. [A case of parkinsonism induced by an oral contraceptive].
No to shinkei = Brain and nerve.
1992 Feb; 44(2):163-6. doi:
NULL. [PMID: 1567736] - P Chopin, M Briley. Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats.
Psychopharmacology.
1992; 106(1):26-30. doi:
10.1007/bf02253584. [PMID: 1738791] - A Sioufi, N Sandrenan, J Godbillon. Determination of 10 alpha-methoxy-9,10-dihydrolysergol, a nicergoline metabolite, in human urine by high performance liquid chromatography.
Biomedical chromatography : BMC.
1992 Jan; 6(1):9-11. doi:
10.1002/bmc.1130060104. [PMID: 1600376] - L D Sidorova, N P Domnikova, A S Logvinenko. [Platelet aggregation inhibitors in the comprehensive treatment of bronchial asthma].
Klinicheskaia meditsina.
1991 Nov; 69(11):47-9. doi:
NULL. [PMID: 1808406] - K Banno, S Horimoto, M Mabuchi. Assay of nicergoline and three metabolites in human plasma and urine by high-performance liquid chromatography-atmospheric pressure ionization mass spectrometry.
Journal of chromatography.
1991 Aug; 568(2):375-84. doi:
10.1016/0378-4347(91)80175-c. [PMID: 1783643] - K Kohlenberg-Müller, D H Meier, K Kunz, C H Wauschkuhn, K Schaffler. [Comparative studies on the bioavailability of nicergoline from two different steady-state preparations].
Arzneimittel-Forschung.
1991 Jul; 41(7):728-31. doi:
NULL. [PMID: 1772461] - Y Nagakawa, Y Akedo, S Kaku, H Orimo. Effect of nicergoline on platelet aggregation, plasma viscosity and erythrocyte deformability in geriatric patients with cerebral infarction. Preliminary report.
Arzneimittel-Forschung.
1990 Aug; 40(8):862-4. doi:
NULL. [PMID: 2122905] - K Shintomi, K Yoshimoto, Y Ogawa, T Itakura, K Ikezawa, H Narita, T Ishizuka, I Yamaguchi, K Yamada. Pharmacological effects of nicergoline and its metabolites, decomposition products and impurities in animals.
Journal of pharmacobio-dynamics.
1987 Jan; 10(1):35-48. doi:
10.1248/bpb1978.10.35. [PMID: 3585694] - Y Ghaddar, J Caissel, P Léandri, G Rossignol. [Pharmacologic study of nicergoline in the pathology of the cervico-prostatic sphincter].
Annales d'urologie.
1987; 21(2):107-14. doi:
NULL. [PMID: 2441642] - B Spinnewyn, N Blavet, F Clostre. [Effects of Ginkgo biloba extract on a cerebral ischemia model in gerbils].
Presse medicale (Paris, France : 1983).
1986 Sep; 15(31):1511-5. doi:
". [PMID: 2947090] - C Dubreuil. [Therapeutic trial in acute cochlear deafness. A comparative study of Ginkgo biloba extract and nicergoline].
Presse medicale (Paris, France : 1983).
1986 Sep; 15(31):1559-61. doi:
". [PMID: 2947099] - F Lanza, J P Cazenave, A Beretz, A Sutter-Bay, J G Kretz, R Kieny. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
Agents and actions.
1986 Aug; 18(5-6):586-95. doi:
10.1007/bf01964968. [PMID: 3020942] - M Albus, C Botschev, F Müller-Spahn, D Naber, U Münch, M Ackenheil. Clinical and biochemical effects of nicergoline in chronic schizophrenic patients.
Pharmacopsychiatry.
1986 May; 19(3):101-5. doi:
10.1055/s-2007-1017164. [PMID: 3725889] - K Shintomi, T Itakura, K Yoshimoto, Y Ogawa, T Fukushima, Y Matsuoka. [Pharmacological study of nicergoline. (II). Protective effect on ischemic brain damages in animals].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica.
1986 Apr; 87(4):427-34. doi:
10.1254/fpj.87.427. [PMID: 3755114] - B Meyer. [A multicenter study of tinnitus. Epidemiology and therapy].
Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris.
1986; 103(3):185-8. doi:
". [PMID: 3530094] - D M Payen, Y A Blanloeil, M L Pinaud, B Lucas. Sustained ventricular unloading action of the alpha-adrenergic antagonist nicergoline in the dog.
Critical care medicine.
1985 Aug; 13(8):656-60. doi:
10.1097/00003246-198508000-00009. [PMID: 3893889] - M Pinaud, Y Blanloeil, D Payen, M Kremer, B Charbonnel, B Lucas. [Plasma renin activity and prostaglandin E2 in hypotension induced by nicergoline].
Annales francaises d'anesthesie et de reanimation.
1985; 4(3):258-63. doi:
10.1016/s0750-7658(85)80136-2. [PMID: 3893236] - B Gessner, A Voelp, M Klasser. Study of the long-term action of a Ginkgo biloba extract on vigilance and mental performance as determined by means of quantitative pharmaco-EEG and psychometric measurements.
Arzneimittel-Forschung.
1985; 35(9):1459-65. doi:
". [PMID: 3910053] - J Gallego, V Forner, F Jimenez, E Martinez. Nicergoline in the treatment of neuropathic bladder dysfunction: a preliminary report.
Paraplegia.
1984 Aug; 22(4):216-24. doi:
10.1038/sc.1984.37. [PMID: 6483464] - M L Pinaud, Y A Blanloeil, D M Payen, B Lucas. Systemic and carotid haemodynamics and plasma renin activity during deliberate hypotension in dogs: a comparison of sodium nitroprusside with nicergoline.
European journal of anaesthesiology.
1984 Mar; 1(1):21-9. doi:
NULL. [PMID: 6399253] - A Bourguignat, P A Tulasne, P Metais. [Variations of enzyme activities and plasma proteins in severe cranial injuries: action of nicergoline].
Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression.
1983 Sep; 24(8):363-6. doi:
NULL. [PMID: 6660360] - L Robert, J Migne, R Santonja, R Zini, K Schmid, J P Tillement. Plasma binding of an alpha-blocking agent, nicergoline--affinity for serum albumin and native and modified alpha 1-acid glycoprotein.
International journal of clinical pharmacology, therapy, and toxicology.
1983 Jun; 21(6):271-6. doi:
NULL. [PMID: 6885199] - F Boismare, N Moore, S Decourt, G Paux, C Saligaut, P Chretien. Potentiation by an alpha-adrenolytic agent, nicergoline, of the cardiac effects of propranolol.
Methods and findings in experimental and clinical pharmacology.
1983; 5(2):83-8. doi:
NULL. [PMID: 6876944] - N Moore, M Chadelaud, B Gügi, C Saligaut, C Berland, P Chrétien, M Daoust, F Boismare. The effects of nicergoline on spontaneously hypertensive rats and their offspring.
Clinical and experimental hypertension. Part A, Theory and practice.
1983; 5(4):613-24. doi:
10.3109/10641968309081796. [PMID: 6851201] - N Moore, M Chadelaud, B Gügi, C Saligaut, P Chretien, M Daoust, F Boismare. Effects of parenteral treatment by nicergoline on the development of hypertension of S.H.R.
Methods and findings in experimental and clinical pharmacology.
1983; 5(2):75-81. doi:
NULL. [PMID: 6348446] - C A Bizollon, J P Rocher, P Chevalier. Radioimmunoassay of nicergoline in biological material.
European journal of nuclear medicine.
1982; 7(7):318-21. doi:
10.1007/bf00253428. [PMID: 7117274] - M Le Poncin-Lafitte, C Grosdemouge, C R Billon, D Duterte, P Pontrat, P Lespinasse, J R Rapin. Short-term memory and cerebral ischemia: pharmacological application.
European neurology.
1981; 20(3):265-9. doi:
10.1159/000115245. [PMID: 7262126] - A Molteni, P A Nickerson, A C Brownie, K Liu. Effect on an ergoline derivate-nicergoline (Sermion) on methylandrostenediol-induced hypertension in the rat.
Archives internationales de pharmacodynamie et de therapie.
1980 Sep; 247(1):119-34. doi:
. [PMID: 7447555] - A Moretti. [Metabolic and neurochemical effects of nicergoline on the central nervous system. A review of the experimental studies (author's transl)].
Arzneimittel-Forschung.
1979; 29(8a):1213-23. doi:
NULL. [PMID: 395953] - R Le Menn, J Migne, R J Probst-Dvojakovic. [Ultrastructural study on the effect of an inhibitor of platelet aggregation (author's transl)].
Arzneimittel-Forschung.
1979; 29(8a):1278-82. doi:
NULL. [PMID: 540072]